Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$5.3M
Filings
25
Firms Hired
1
Active Period
2021–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
DMEPOS Relief Act of 2025
2026 · third_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $200,000 · Firm income: —
Matched citations: H.R. 2005
SOAR Act of 2025
2026 · third_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $200,000 · Firm income: —
Matched citations: H.R. 2902
DME Scammer Prevention Act of 2026
2026 · third_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $200,000 · Firm income: —
Matched citations: H.R. 8871
SOAR Act of 2025
2026 · third_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $200,000 · Firm income: —
Matched citations: S. 1406
Competitive Bidding Relief Act
2026 · third_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $200,000 · Firm income: —
Matched citations: S. 2951
Diabetes Act
2026 · third_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $200,000 · Firm income: —
Matched citations: S. 4037
DMEPOS Relief Act of 2025
2026 · second_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $250,000 · Firm income: —
Matched citations: H.R. 2005
SOAR Act of 2025
2026 · second_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $250,000 · Firm income: —
Matched citations: H.R. 2902
DME Scammer Prevention Act of 2026
2026 · second_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $250,000 · Firm income: —
Matched citations: H.R. 8871
SOAR Act of 2025
2026 · second_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $250,000 · Firm income: —
Matched citations: S. 1406
Competitive Bidding Relief Act
2026 · second_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $250,000 · Firm income: —
Matched citations: S. 2951
Diabetes Act
2026 · second_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $250,000 · Firm income: —
Matched citations: S. 4037
DMEPOS Relief Act of 2025
2026 · second_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $250,000 · Firm income: —
Matched citations: H.R. 2005
SOAR Act of 2025
2026 · second_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $250,000 · Firm income: —
Matched citations: H.R. 2902
DME Scammer Prevention Act of 2026
2026 · second_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $250,000 · Firm income: —
Matched citations: H.R. 8871
SOAR Act of 2025
2026 · second_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $250,000 · Firm income: —
Matched citations: S. 1406
Competitive Bidding Relief Act
2026 · second_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $250,000 · Firm income: —
Matched citations: S. 2951
Diabetes Act
2026 · second_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $250,000 · Firm income: —
Matched citations: S. 4037
DMEPOS Relief Act of 2025
2026 · first_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., the "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4307) and the "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, the "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $280,000 · Firm income: —
Matched citations: H.R. 2005
SOAR Act of 2025
2026 · first_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., the "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4307) and the "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, the "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $280,000 · Firm income: —
Matched citations: H.R. 2902
SOAR Act of 2025
2026 · first_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., the "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4307) and the "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, the "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $280,000 · Firm income: —
Matched citations: S. 1406
Competitive Bidding Relief Act
2026 · first_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., the "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4307) and the "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, the "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $280,000 · Firm income: —
Matched citations: S. 2951
Protecting American Consumers from Robocalls Act
2026 · first_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., the "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4307) and the "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, the "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $280,000 · Firm income: —
Matched citations: S. 4307
DMEPOS Relief Act of 2025
2025 · fourth_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., DMEPOS Relief Act of 2025 [H.R. 2005, S. 2951], competitive bidding and the Supplemental Oxygen Access Reform [SOAR] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement.
Client expense: $240,000 · Firm income: —
Matched citations: H.R. 2005
SOAR Act of 2025
2025 · fourth_quarter · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to access to home medical equipment and related reimbursement (i.e., DMEPOS Relief Act of 2025 [H.R. 2005, S. 2951], competitive bidding and the Supplemental Oxygen Access Reform [SOAR] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement.
Client expense: $240,000 · Firm income: —
Matched citations: H.R. 2902
Source: Senate LDA